Effective use of transdermal drug delivery in children

Advanced Drug Delivery Reviews
M Begoña Delgado-Charro, R H Guy

Abstract

Transdermal administration offers a non-invasive and convenient method for paediatric drug delivery. The competent skin barrier function in term infants and older children limits both water loss and the percutaneous entry of chemicals including drugs; but the smaller doses required by children eases the attainment of therapeutic concentrations. Transdermal patches used in paediatrics include fentanyl, buprenorphine, clonidine, scopolamine, methylphenidate, oestrogens, nicotine and tulobuterol. Some patches have paediatric labelling supported by clinical trials whereas others are used unlicensed. Innovative drug delivery methods, such as microneedles and sonophoresis are being tested for their safety and efficacy; needleless injectors are primarily used to administer growth hormone; and two iontophoretic devices were approved for paediatrics. In contrast, the immature and rapidly evolving skin barrier function in premature neonates represents a significant formulation challenge. Unfortunately, this population group suffers from an absence of approved transdermal formulations, a shortcoming exacerbated by the significant risk of excessive drug exposure via the incompletely formed skin barrier.

References

Apr 1, 1979·The Journal of Pediatrics·T F YehR S Pildes
May 1, 1979·Acta paediatrica Scandinavica·K HammarlundG Sedin
May 1, 1979·Archives of Disease in Childhood·J CowenJ McAinsh
Sep 1, 1992·American Journal of Perinatology·M AmatoH Schneider
Jun 1, 1991·European Journal of Pediatrics·M AmatoP Hüppi
Jan 1, 1991·Pediatric Research·P M MackayP C Ng
Apr 1, 1991·The British Journal of Dermatology·M Turpeinen
May 1, 1991·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Y HorimotoY Nishida
May 1, 1990·British Journal of Clinical Pharmacology·R G CartwrightS S Davis
Nov 1, 1987·Pediatric Dermatology·D P WestJ I Harper
Jan 1, 1986·Biology of the Neonate·N J Evans, N Rutter
Aug 1, 1985·The Journal of Pediatrics·N J EvansG Parr
Aug 7, 1971·Lancet·A CurleyL Finberg
Oct 1, 1974·American Journal of Diseases of Children·P R Williams, W Oh
Oct 1, 1971·The Journal of Pediatrics·R L Nachman, N B Esterly
Jan 1, 1983·Acta Paediatrica Scandinavica. Supplement·G SedinB Strömberg
Mar 1, 1983·The Journal of Pediatrics·V A Harpin, N Rutter
Jun 1, 1982·Archives of Disease in Childhood·V Harpin, N Rutter
Nov 1, 1981·Archives of Disease in Childhood·P J AggettJ McAinsh
May 1, 1980·Acta paediatrica Scandinavica·K Hammarlund, G Sedin
Jul 1, 1994·The Journal of Pediatric Endocrinology·T W AvRuskinC S Juan
Jan 1, 1994·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·P C ChangJ A Stewart
Jun 1, 1993·The British Journal of Dermatology·K Aalto-Korte, M Turpeinen
Nov 1, 1996·Archives of Otolaryngology--head & Neck Surgery·E S Deutsch, V M Nadkarni
Oct 6, 1997·Journal of the American Academy of Dermatology·F B de Waard-van der SpekA P Oranje
Jan 10, 1998·Journal of Pharmaceutical Sciences·N G Turner, R H Guy
May 29, 1998·The British Journal of Dermatology·C C LongA Y Finlay
Aug 12, 1998·The Journal of Investigative Dermatology·Y N KaliaR H Guy
Jan 20, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·J J Broderick-Cantwell
Apr 17, 1999·International Journal of Pharmaceutics·P SinghS Dinh
Dec 14, 1999·The Journal of Investigative Dermatology·M J HardmanC Byrne
Dec 22, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·D F ConnorJ M Swanson
Mar 29, 2000·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·S J SquireK Hissong

❮ Previous
Next ❯

Citations

Jul 28, 2015·Psychosomatics·Jonathan R StevensTheodore A Stern
Jan 7, 2015·British Journal of Pharmacology·Michael N PastoreMichael S Roberts
Jul 22, 2015·International Journal of Pharmaceutics·C E Serna-JiménezV Merino
Nov 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kevin Ita
Dec 30, 2016·The Journal of Pharmacy and Pharmacology·Sara M HanningUNKNOWN CloSed Consortium
Jun 5, 2019·International Journal of Molecular Sciences·Fiona O'BrienCatherine Tuleu
Nov 27, 2019·Journal of Palliative Medicine·Michael SmythMarie-Claude Gregoire
Feb 6, 2018·Advanced Pharmaceutical Bulletin·Rabinarayan Parhi
Mar 25, 2020·Journal of Ethnobiology and Ethnomedicine·Madalina PetranMarilena Gilca
Jul 9, 2017·Clinical Pharmacokinetics·Victoria C ZiesenitzJohannes N van den Anker
Nov 28, 2017·Clinical Pharmacokinetics·Victoria C ZiesenitzJohannes N van den Anker
Dec 21, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Takaki AmamotoMasaru Kato
Sep 19, 2019·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sin Yin Lim, Rebecca S Pettit
Oct 28, 2020·Paediatric Drugs·Anthony L Kovac
Sep 9, 2019·Advanced Drug Delivery Reviews·Venkata K YellepeddiElizabeth Nance
Apr 24, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Songyu LiuJunzhi Lin
Jul 4, 2019·Biomedical Physics & Engineering Express·Yu Ri LeeDo-Geun Kim
Jul 13, 2018·Molecular Pharmaceutics·Aaron J CourtenayRyan F Donnelly

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Pharmaceutical Sciences
Heather A E Benson, Sarika Namjoshi
AAPS PharmSciTech
Haripriya Kalluri, Ajay K Banga
Expert Opinion on Drug Delivery
Priya BathejaMichniak Bozena
© 2021 Meta ULC. All rights reserved